Jennifer Jarrett

Companies

• Damora Therapeutics, Inc.Chief executive officer Sep 28, 2026 to now¹
• Damora Therapeutics, Inc.President Sep 28, 2026 to now¹
• Damora Therapeutics, Inc.Board member Apr 1, 2026 to now²
• Damora Therapeutics, Inc.Officer Apr 1, 2026 to now²
• Sagimet Biosciences Inc.Board member Aug 5, 2024 to now³
• Zura Bio LtdBoard member Mar 21, 2023 to now⁴
• Arcus BiosciencesChief operating officer Oct 5, 2020 to now⁵
• Syndax Pharmaceuticals IncBoard member Sep 27, 2018 to now⁶
• Arcus BiosciencesBoard member Jan 15, 2019 to Jan 25, 2024⁷
• Radius Health, Inc.Board member May 20, 2022 to Aug 15, 2022⁸
• Arena PharmaceuticalsBoard member Jun 14, 2017 to Mar 11, 2022⁹
• Surrozen, Inc./DEBoard member Nov 18, 2020 to Nov 18, 2020¹⁰
• Audentes Therapeutics, Inc.Board member Jun 13, 2017 to Jan 15, 2020¹¹
• Arcus BiosciencesOfficer Mar 14, 2018 to Jun 12, 2018¹²
• MedivationChief financial officer Apr 8, 2016 to Sep 30, 2016¹³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• DTDamora Therapeutics, Inc. DMRA512,500 shares¹⁴$9.4M at $18.32Sep 25, 2026
• ABArcus Biosciences RCUS224,024 shares¹⁵$4.9M at $21.66Jan 23, 2026
• SPSyndax Pharmaceuticals Inc SNDX114,000 shares¹⁶$1.5M at $13.05Feb 4, 2026
• Arena Pharmaceuticals ARNA0 shares¹⁷Mar 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 25, 2026Bought 12,500 shares at $20.23 of Damora Therapeutics, Inc.¹⁴
• Mar 30, 2026Granted 500,000 shares of Damora Therapeutics, Inc.¹⁸
• Feb 4, 2026Granted 24,000 shares of Syndax Pharmaceuticals Inc¹⁶
• Jan 23, 2026Granted 31,000 shares of Arcus Biosciences¹⁵
• Dec 17, 2025Sold 9,983 shares at $22.16 of Arcus Biosciences¹⁹
• Dec 16, 2025Sold 11,225 shares at $21.88 of Arcus Biosciences¹⁹
• Nov 7, 2025Sold 50,291 shares at $18.97 of Arcus Biosciences²⁰
• Nov 7, 2025Exercised options 50,291 shares at $1.23 of Arcus Biosciences²⁰
• Oct 8, 2025Sold 37,792 shares at $15.05 of Arcus Biosciences²¹
• Oct 8, 2025Exercised options 37,792 shares at $1.23 of Arcus Biosciences²¹
• Oct 6, 2025Sold 12,500 shares at $14.54 of Arcus Biosciences²¹
• Oct 6, 2025Exercised options 12,500 shares at $1.23 of Arcus Biosciences²¹
• Feb 5, 2025Granted 25,000 shares of Syndax Pharmaceuticals Inc²²
• Jan 23, 2025Granted 50,000 shares of Arcus Biosciences²³
• Dec 15, 2024Shares withheld for tax 27,501 shares at $16.08 of Arcus Biosciences²⁴
• Sep 15, 2024Shares withheld for tax 12,670 shares at $17.95 of Arcus Biosciences²⁵
• Jun 15, 2024Shares withheld for tax 12,670 shares at $16.97 of Arcus Biosciences²⁶
• Mar 27, 2024Sold 11,551 shares at $17.55 of Arcus Biosciences²⁷
• Mar 18, 2024Sold 1,296 shares at $18.62 of Arcus Biosciences²⁸
• Mar 18, 2024Sold 12,153 shares at $17.84 of Arcus Biosciences²⁸
• Feb 27, 2024Sold 34,070 shares at $20.11 of Arcus Biosciences²⁹
• Feb 26, 2024Sold 24,555 shares at $20.07 of Arcus Biosciences²⁹
• Feb 7, 2024Granted 17,000 shares of Syndax Pharmaceuticals Inc³⁰
• Jan 23, 2024Granted 40,000 shares of Arcus Biosciences³¹
• Dec 22, 2023Sold 21,521 shares at $17.76 of Arcus Biosciences³²